Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the efficacy and safety of itacitinib in combination with corticosteroids as first-line treatment for moderate or severe chronic graft-versus-host disease (cGVHD...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Incyte Corporation
NCT06660355 · Chronic Graft-versus-host Disease (cGVHD)
NCT02611180 · Acute Graft-versus-host Disease, Acute GVHD, and more
NCT01366092 · Chronic Graft-versus-host Disease
NCT02759731 · Chronic Graft vs Host Disease, Chronic Graft-Versus-Host Disease
NCT05885451 · Chronic Graft-versus-Host Disease (cGVHD)
University of Arizona Cancer Center - Out Pt.
Tucson, Arizona
University of Arkansas For Medical Sciences - Winthrop P Rockefeller Cancer Institute
Little Rock, Arkansas
City of Hope National Medical Center
Duarte, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions